GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of how much of what we believe about pharmacy actually comes from EMA threads — 37 comments in the full submission. View in context.
1.7k
c/glp1eu·submitted 1 year ago by u/erez_yilmaz

how much of what we believe about pharmacy actually comes from EMA threads

Pricingbranch of 10 comments

how much of what we believe about pharmacy actually comes from EMA threads. If this has been answered properly somewhere, link me and I will delete. On cross-border prescriptions, since the assumption behind half these threads is wrong. There are EU rules on the recognition of prescriptions issued in another member…

Read the full submission and all 37 comments →

This branch

10 comments, started 1 year ago
u/sten_bhattacharya356 points·1 year ago

Published reimbursement criteria exist in most member states and are usually available in the national language. They are the authoritative answer to eligibility questions that this board can only guess at.

replysharereportpermalink
u/mikkel_correia287 points·1 year ago

Careful, that guidance is from a different country and this thread is asking about somewhere else entirely.

replysharereportpermalink
u/diego_iyer69 points·1 year ago

What pack size is that price for?

replysharereportpermalink
u/cesar_oyelaran93 points·1 year ago

What pack size is that price for?

This is the split the whole board depends on. Authorisation is European; payment is national.

replysharereportpermalink
[removed]141 points·1 year ago

[removed by moderator]

replysharereportpermalink
u/erez_yilmazOP212 points·1 year ago

Reimbursed or private?

replysharereportpermalink
u/coring_the_stopper95 points·1 year ago

EU-wide advice is almost always wrong somewhere

replysharereportpermalink
u/vito_chowdhury50 points·1 year ago

pack sizes differ, so per-month comparisons need care

replysharereportpermalink
u/nadia_bakker31 points·1 year ago

pack sizes differ, so per-month comparisons need care

vito_chowdhury is right about cross-border recognition being narrower than the summaries suggest.

replysharereportpermalink
u/oskar_malinowski61 points·1 year ago

keep the prescription and the receipt, both matter for claims

replysharereportpermalink

← back to the whole thread

About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.